Skip to content

Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic Perfusion

Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic Perfusion

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000002965
Enrollment
Unknown
Registered
2020-02-03
Start date
2020-02-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequelae of PID

Interventions

Sponsors

Xianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: From February 20,2020 to May 31,2022, females aged 18-55 years, who were diagnosed in the hospital according to the western medicine criteria of sequela of pelvic inflammatory disease and the standards of TCM syndrome of pelvic inflammatory disease of accumulated damp heat according to traditional Chinese medicine.

Exclusion criteria

Exclusion criteria: 1. Patients with severe diseases of heart, liver, kidney and hematopoietic system; 2. Women in pregnancy or to be pregnant in near future or in lactation period; 3. Women who are unable to cooperate, such as those with neurological or mental disorders, or unwilling to cooperate; 4. Those with allergic constitution or multiple drug allergy; 5. Those who have recently used similar drugs for treatment, such as taking drugs with related or antagonistic effects, resulting in difficulty in judging the efficacy of the drugs.

Design outcomes

Primary

MeasureTime frame
TNF-a;ICAM-1;IL-2;Pelvic sign score;TCM score;IL-6;

Secondary

MeasureTime frame
TV;age;NG;CA;BV;vagina cleaness;CT;UU;

Countries

China

Contacts

Public ContactChen Yao
chenyao.1973@163.com+86 13892991356

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026